Surprisingly, our data found that endocrine resistance pathways, which could be divided into 3 functional categories, ERBB2, BCL2, and CCND1, were upregulated in FA-derived breast cancer compared to FA component. This evidence concerns the gene ERBB2 and breast carcinoma.